255 related articles for article (PubMed ID: 26190526)
41. Angiogenesis inhibition in the treatment of lung cancer.
Vokes E; Herbst R; Sandler A
Clin Adv Hematol Oncol; 2006 Nov; 4(11 Suppl 23):1-10; quiz 11-2. PubMed ID: 17143257
[TBL] [Abstract][Full Text] [Related]
42. [Anti-angiogenic therapy for gastrointestinal tumours].
Graepler F; Gregor M; Lauer UM
Z Gastroenterol; 2005 Mar; 43(3):317-29. PubMed ID: 15765305
[TBL] [Abstract][Full Text] [Related]
43. Angiogenesis inhibitors in early development for gastric cancer.
Pinto MP; Owen GI; Retamal I; Garrido M
Expert Opin Investig Drugs; 2017 Sep; 26(9):1007-1017. PubMed ID: 28770623
[TBL] [Abstract][Full Text] [Related]
44. Emerging antiangiogenic agents in lung cancer.
Lee D; Heymach JV
Clin Lung Cancer; 2006 Mar; 7(5):304-8. PubMed ID: 16640800
[TBL] [Abstract][Full Text] [Related]
45. Breast tumour angiogenesis.
Fox SB; Generali DG; Harris AL
Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723
[TBL] [Abstract][Full Text] [Related]
46. [Antiangiogenic therapy for gastrointestinal tumors].
Lakatos G; Tulassay Z
Orv Hetil; 2008 Dec; 149(49):2317-24. PubMed ID: 19042183
[TBL] [Abstract][Full Text] [Related]
47. Antiangiogenic therapy in nonsmall cell lung cancer.
Gutierrez M; Giaccone G
Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
[TBL] [Abstract][Full Text] [Related]
48. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
Jain RK
Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
[TBL] [Abstract][Full Text] [Related]
49. Ramucirumab: targeting angiogenesis in the treatment of gastric cancer.
Smyth EC; Tarazona N; Chau I
Immunotherapy; 2014; 6(11):1177-86. PubMed ID: 25496333
[TBL] [Abstract][Full Text] [Related]
50. Targeting VEGF in lung cancer.
Das M; Wakelee H
Expert Opin Ther Targets; 2012 Apr; 16(4):395-406. PubMed ID: 22439677
[TBL] [Abstract][Full Text] [Related]
51. Ramucirumab and its use in gastric cancer treatment.
Bronte G; Galvano A; Cicero G; Passiglia F; Rolfo C; Bazan V; Russo A
Drugs Today (Barc); 2014 Sep; 50(9):613-21. PubMed ID: 25313368
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches.
Poon RT; Fan ST; Wong J
Ann Surg; 2003 Jul; 238(1):9-28. PubMed ID: 12832961
[TBL] [Abstract][Full Text] [Related]
53. Targeting tumor neovasculature in non-small-cell lung cancer.
Pallis AG; Syrigos KN
Crit Rev Oncol Hematol; 2013 May; 86(2):130-42. PubMed ID: 23159217
[TBL] [Abstract][Full Text] [Related]
54. Angiogenic inhibitors: a new therapeutic strategy in oncology.
Gasparini G; Longo R; Toi M; Ferrara N
Nat Clin Pract Oncol; 2005 Nov; 2(11):562-77. PubMed ID: 16270097
[TBL] [Abstract][Full Text] [Related]
55. Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer.
Aita M; Fasola G; Defferrari C; Brianti A; Bello MG; Follador A; Sinaccio G; Pronzato P; Grossi F
Crit Rev Oncol Hematol; 2008 Dec; 68(3):183-96. PubMed ID: 18606548
[TBL] [Abstract][Full Text] [Related]
56. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
57. Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer.
Quesada AR; Medina MA; Alba E
Bioessays; 2007 Nov; 29(11):1159-68. PubMed ID: 17935210
[TBL] [Abstract][Full Text] [Related]
58. Angiogenesis inhibitors in the treatment of lung cancer.
Sun S; Schiller JH
Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557
[TBL] [Abstract][Full Text] [Related]
59. Apatinib: a promising oral antiangiogenic agent in the treatment of multiple solid tumors.
Scott AJ; Messersmith WA; Jimeno A
Drugs Today (Barc); 2015 Apr; 51(4):223-9. PubMed ID: 26020064
[TBL] [Abstract][Full Text] [Related]
60. Ramucirumab for gastric cancer.
Shitara K; Ohtsu A
Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):133-9. PubMed ID: 25431958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]